Bibliografía

1. Tratamiento Clínico de la Hipertensión, Marvin Mosser, MD. 2da. Ed, Editorial Intersistema S.A de C.V. México, 2003. Pág.: 13 – 23.

2. Manual de Terapéutica Médica, Salvador Subirán, 4ta Edición, McGraw - Hill Interamericana, México 2005, Pág.: 87 – 97.

3. Manual Merck de Diagnóstico y Terapéutica, Francesc Cardellach López,9na Edición, Editorial Océano, Barcelona – España 1994. Pág.: 457 – 472.

4. Bases Farmacológicas de la Terapéutica, Alfred Goodman Gilman, 8vaEdición, Editorial Médica Panamericana S.A. de C.V. Marcelo T de Alvear2145, Buenos Aires, 1999, Pág.: 740 – 743.

5. Medicina Interna Diagnóstico y Tratamiento, Jay H Stein 3ra Edición, Manuales Clínicos Editorial Panamericana, Buenos Aires Argentina 1995, Pág.: 171 – 175.

6. Diagnóstico y Tratamiento en Medicina Interna, Consultor Clínico, Fred F, Ferri. 1ra. Editorial Océano, Pág.: 276 – 277. 2005

7. Evaluación de la terapia de drogas para el tratamiento de la urgencia hipertensiva en el departamento de emergencia (Nifedipina / Clonidina). VL. Justo Schnader publicación médica 1991.

8. Eficacia del Captopril y la Nifedipina Sublingual en pacientes Negros y Blancos con crisis Hipertensiva. Damasceno A. Ferreira B., Publicación Médica, Aug: (8) 471-6 1997.

9. Comparación entre el Captopril Sublingual e Isosorbide en aerosol para el manejo de las crisis Hipertensiva. Rubio Gof Vargas, A. G. Rodríguez, Revista Mexicana de Cardiología; 9 (3): 81-85, 2007.

10. Medicina Interna, Jay H, Stein, 3ra. Edición, Salvat Editores S.A. Mallorca47 Barcelona España 1991, Pág.: 238 - 254.

11. Hernández R, Armas MC, Armas MJ y Velasco M. Hipertensión y Salud Cardiovascular en Venezuela y Países Latinoamericanos. Journal of Human Hypertension, 2000; 14(1): 2-5.

12. The Seventh Report of the Joint National Committee on prevention, Detection Evaluation and Treetmet of high blood Presure, Jama, Mayo 21,2003. Vol., 289. No. 19.

13. Principios de Medicina Interna, Harrison, Kurt J. Isselbacher, 13va. Ed, Interamericana Mcgraw – Hill Manuel Farero–28036 MadridEspaña 1994. Pág.: 1286 - 1303.

 14. Diagnostico Clínico y Tratamiento, Lawrence Tierney Jr, MD. 37va. Edición, Manual Moderno, México, 2002, Pág.: 469 – 472.

15. Manual de Medicina de Urgencias, 4ta. Edición, David M, Clene MacGraw –Hill Interamericana, Editores SA de CV. México 1999. Pág.: 247 – 251.

16.Manual Washington de Terapéutica Médica, departamento de Medicina Interna, Universidad de Washington, San Luis Missouri, 10ª Edición 2001,Series de Manuales Espirales.

17. Medicina basada en evidencia, Hospital General de Massachusetts, 2005.Editorial Marban, Libro S. L.

18. Fontanet H. The use of isosorbide in the treatment of severe, uncontrolled hipertension. Arch Intern Med 1987;147: 426-8.

19. Houston MC. Hypertension. Current therapy. Philadelphia: W.B. Saunders, 2006:293-307.

20. The Fifth Report of the Joint National Committee on Detection. Evaluation and treatment of high blood pressure. (JN CV) Arch Intern Med 1993:153:154-83.

21. Pozo H del, Llorenz M, Pérez G. Hipertensión arterial y preoperatorio. Acta Méd 1997;7(1):161-6.

22. Pannier BM, Kando T, Safarian AA, Isnard RN, Diebold B, Safar M. Altered hemodynamic response to isosorbide dinitrate in esential hypertension. J Clin Pharmacol 2002;30(2):127-32.

23. Riesgo Cardiovascular de Hipertensión Arterial a la Cardiopatia Isquemica,X Congreso Europeo de Hipertensión Arterial, Editorial Eurpa Pres, 2002.

24. Barry M. Massie, Systemic Hypertension. En: Current Medical Diagnosis & Treatment. 38a ed, 2005.

25. Lenfant Claude. Conquering Cardiovascular Disease. Progrese and Promise. JAMA. 1999; 282: 1-5.

26. Oparil S, Calhoun DA. High Blood pressure. En: Dale DC, Federman DD eds. Scientific American Medicine. New York: Healtheon; 2006; 3-15.

27. Trilling JS, Froom J. The urgent need to improve hypertension care. Arch Fam Med 2000; 9: 794-801.

28. Van den Hoogen PC. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med 2006; 342: 1-8.

29. The VI Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-22.

30. Lyons A. Medicine, an illustrated history. Abrams Publishers, New York, 1978; 477-593.

31. Medical Diccionary, 26a ed. Saunders & Co. Filadelfia, 1985.

32. Castiglione A. Historia de la Medicina. Salvat Editores. Barcelona, 2004; 209-524.

33. González-Juanatey JR, Alegría Ezquerra E, Lozano Vidal JV, Llisterri Caro JL, García Acuña JM, González Maqueda I... Impacto de la hipertensión en las cardiopatías en España. Estudio Cardiotens 1999. Rev Esp Cardiol 2001; 54:139-49.

34. Lombera Romero F, Barrios Alonso V, Soria Arcos F, Placer Peralta L, Cruz Fernández JM, Tomás Abadal L, et al... Guías de práctica clínica de la Sociedad Española de Cardiología en hipertensión arterial. Rev Esp Cardiol 2000; 53:66-90.

35. Weisser B, Mengden T, Dusing R, Vetter H, Vetter W.. Normal values of blood pressure self-measurement in view of the 1999 World Health Organization-International Society of Hypertension guidelines. Am J Hypertens 2006; 13:940-3?

36. Schettini C, Bianchi M, Nieto F, Sandoya E, Senra H.. Ambulatory blood pressure: normality and comparison with other measurements. Hypertension WorkingGroup.Hypertension1999; 34:818-25.

37. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB... Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994;90:1786-93.
38. Lip GY.. Regression of left ventricular hypertrophy and improved prognosis: some hope now or hype? Circulation 2003; 104: 1582-4.

39. Konstam M, Dracup K, Baker D, et al. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Clinical Practice Guideline No. 11. AHCPR Publication no. 94—0612. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services. June 1994.

40. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:303—10.

41. Aquilina, S.; Felice, H.; Boffa, M. J. Allergic reactions to glyceryl trinitrate and isosorbide dinitrate demonstrating cross-sensitivity. Clinical & Experimental Dermatology, Nov2002, Vol. 27 Issue 8, p700- 704.

42. Gunasekara, N.S.; Noble, S. Isosorbide 5-Mononitrate: A Review of a Sustained-Release Formulation (Imdur) in Stable Angina Pectoris: Drugs, Feb 2003, Vol. 57 Issue 2, p261,

43. Chebonian AV., Bakris GL, Blanck HR, et al.The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.JAMA, 2003;289: (DOI 10.1001/Jama 289.19.2560).

44. Galazka M, Ruddy MC, Bialy GB. Systolic Hypertension remains difficult to control despite refferal to hypertension specilists. American Journal of Hypertension. 2004; 17: s144.

45. Ppademetriou V, Farsang C, Elmfreldt E. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension. The study on cognition and prognosis in the elderly (SCOPE). Journal of the American College of Cardiology.2004;44: 1175-1180.

46. Van Zwieten Peter A.Drug Treatment of isolated systolic hypertension. Nephrol Dial Transplant. 2001; 16:1095-1097.

47. Jee SH, Miller ER 3rd, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002;15(8):691-6.

48. Noordzij M, Uiterwaal CS, Arends LR, et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 2005;23(5):921-8.

49. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002; 288:1882–1888.

50. Grossman E, Nadler M, Sharabi Y,et al. Antianxiety treatment in patients with excessive hypertension. Am J Hypertens. 2005; 18:1174-7.

51. Medrano MJ, Cerrato E, Boix R, et al. Cardiovascular risk factors in Spanish population:metaanalysis of cross-sectional studies. Med Clin 2005; 30; 124(16):606-12.

52. Whelton SP, Chin A, Xin X, et al. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Aust J Physiother 2002; 48(3):238.).

53. Garcia-Vera MP, Sanz J, Labrador FJ. Blood pressure variability and stress management training for essential hypertension. Behav Med 2004; 30(2):53-62.

54. Van den Hoogen PCV, Feskens EJM, Nagelkerke NJD, et al. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Eng J Med 2000; 342:1-8.

55. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment control in five European countries, Canada and the United Status. Hypertension. 2004;43:10-17.

56. Murrell W. Nitroglycerin as a remedy for angina pectoris Lancet 1879:1:80-81.

57. Rubio Guerra. Med. Interna Méx; 14(3):89-92, mayo-jun. 1998. tab.

58. Rubio Guerra. Rev. Fac. Med. UNAM; 42(4):148-50, jul.-ago. 1999. Tab.

59. Watcher RM. Symptomatic hypotension induced by Nifedipine in the acute treatment of severe hypertension. Arch Intern Med 1987; 147:556-60

60. Medicina para la Práctica Clínica, J. Willis Hurst, 4ta. Edición, Editorial Médicos Panamericano. S.A. Marcelo T de Alveur 2145 Buenos Aires Argentina 2002, Pág.: 1082 – 1087.

61. The Sixth Report f the Joint National Committee on Prevention,Detection, Evaluation and Treatment of High Blood Pressure.Arch Intern Med 1997;57:2413-46.

62. Morales González JA, Gutiérrez Salinas J, García Acosta VM, Cascomunive R, y col. Urgencia y emergencia hipertensivas. Med Int Mex 2000; 16(4):198-203.

63. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000; 356:411- 17.

64. Elizondo Argueta S, Sánchez Zúñiga MJ, Román López E. Hipertensión arterial sistémica. Diagnóstico y tratamiento. Med Int Mex 2004;20:130-9.

65. Varon J, Marik PE. The diagnosis and management of hypertensive crisis. Chest 2000;18:214-27.

66. Hypertetension clinical guideline. 2001. S Afr Med J 2001;91(2pt 2):163-72.

67. Palma Aguirre JA, Castañeda Hernández G. Nifedipina. Farmacocinética Y adecuado uso terapéutico. Rev Med IMSS 1999; 37(1):47-58.

68. Gracia Moll M. Principles and rules of the nitrates. Ann Cardiol Angiol 1997; 46(7):399-05(Abstract).

69. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris.N Engl J Med 1998; 338(8):520-31

70. Vargas Ayala G, Rubio Guerra FA. El óxido nítrico: más que un factor relajante endotelial. Med Int Mex 1996;12(2):110-15.

71. Rubio Guerra F, Castañeda Hernández G. Valoración de tres Fármacos para el manejo no parenteral de las crisis hiperten-sivas. Med Int Mex 1998; 14(3):89-92.

72. Rubio Guerra AF, Vargas Ayala G. Comparación entre captopril Sublingual e isosorbide en aerosol para el manejo de las crisis hipertensivas. Rev Mex Cardiol 1998;9(3):81-85.

73. Rubio Guerra AF, Vargas Ayala G. Comparison between isosorbide dinitrate aerosol and nifedipine in the treatment of hypertensive emergencies. Angiology 2005; 50(2):147-42.

74. Velasco Rodríguez VM, Martínez Ordaz VA, Roiz Hernández J, Huazano García F, Nieves Rentería A. Muestreo y tamaño de muestra. Una guía práctica para personal de salud que realiza investigación. E-libro net.2003; Pág.: 59.

75. Vargas Ayala G, Rubio Guerra AF, Rodríguez López L, Narváez Rivera JL, et al. Comparison between isosorbide dinitrate in aerosol and in tablet form for the treatment of hypertensive emergencies in the elderly. Blood Press 2000; 9(5):283-86.

76. Rubio Guerra AF, Rodríguez López L, Vargas Ayala G, Lozano Nuevo JJ, et al. Management of hypertension emergencies in elderly patients with isosorbide dinitrate aerosol. Gac Med Mex 2000; 136(1):17-21.

77. Martínez Abundis E, González Ortiz M, Hernández Salazar F, Huerta J, Lucas MT. Sublingual isosorbide dinitrate in the acute control of hypertension in patients whit severe preclamsia. Gynecol Obstet Invest 2000; 50(1):39-42.

78. Fonseca Reyes S, Parra Carrillo JZ. Diagnóstico y tratamiento de la crisis hipertensiva. Med Int Mex 2003;10(3):165-74.

79. Rosas M, Pastelin G, Martínez Reding J, Herrera Acosta J,Attie A. Hipertensión Arterial en México. Guías y recomendaciones para su detección, control y tratamiento. Arch Cardiol Mex 2004; 74:134-57.

80. Gegenhuber A, Lenz K. Hypertensive emergency and urgence.Herz 2007; 28(8):717-24.